Edesa Biotech
EDSA
11 hedge funds and large institutions have $90K invested in Edesa Biotech in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
150% more capital invested
Capital invested by funds: $36K → $90K (+$54K)
22% more funds holding
Funds holding: 9 → 11 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$53.8K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$51.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
-$23.6K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$318 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $40K | +$51.9K | +163 | +2,717% |
|
|
2
Renaissance Technologies
New York
| $40K | +$53.8K | +169 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $4K | +$5.41K | +17 | New |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $1K | -$23.6K | -74 | -95% |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
|
CFD
7
Creative Financial Designs
Kokomo,
Indiana
| $1K | – | – | – |
|
|
WAS
8
WESPAC Advisors SoCal
Pasadena,
California
| $1K | – | – | – |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$318 | -1 | -50% |
|
EDSA Hedge Fund Activity: Q4 2017 in Review
11 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2017, worth a combined $90K — up 150% from $36K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $53.8K. The largest seller was Advisor Group, cutting an estimated $23.6K.
- 11 institutional investors held Edesa Biotech (EDSA) as of Q4 2017, up from 9 in Q3 2017.
- Funds reported $90K of Edesa Biotech stock for Q4 2017, up 150% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q4 2017 and 0 closed out, a net change of +2 holders.
- The largest Edesa Biotech buyer in Q4 2017 was Renaissance Technologies, an estimated $53.8K added.
- The largest Edesa Biotech seller in Q4 2017 was Advisor Group, an estimated $23.6K sold.
Based on aggregated 13F filings for Q4 2017.